Santaris Pharma, Pfizer extend collaboration pact
Santaris Pharma and Pfizer have extended their collaboration pact to discover, develop and commercialize RNA-targeted medicines using Santaris Pharma Locked Nucleic Acid Drug Platform.
Astex Therapeutics, the leading fragment-based drug discovery company, today announced that it has successfully achieved two scientific milestones in its drug discovery collaboration with Janssen Pharmaceutica NV.